{"id":1340,"date":"2026-09-16T14:00:46","date_gmt":"2026-09-16T06:00:46","guid":{"rendered":"https:\/\/www.jingfenggroup.com\/human-health-fulvic-acid\/metabolic-endocrine\/"},"modified":"2026-10-21T01:28:37","modified_gmt":"2026-10-20T17:28:37","slug":"metabolic-endocrine","status":"publish","type":"page","link":"https:\/\/www.jingfenggroup.com\/tr\/metabolic-endocrine\/","title":{"rendered":"Fulvik Asit Vaka Raporlar\u0131 \u2014 Metabolik ve Endokrin"},"content":{"rendered":"<div class=\"jf-case-wrap\">\n<style>.jf-case-wrap{max-width:1320px;margin:0 auto;padding:34px 20px 60px;font-family:-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif;color:#1f2d2d;line-height:1.7}.jf-case-hero{position:relative;overflow:hidden;background:linear-gradient(135deg,#004d4d,#008080);color:#fff;border-radius:14px;padding:38px 40px;margin-bottom:24px}.jf-case-hero h1{color:#fff!important;font-size:31px;margin:0 0 10px;line-height:1.25}.jf-case-hero p{color:#e6f5f5!important;max-width:760px;font-size:16px;margin:0}.jf-case-hero-art{position:absolute;right:24px;top:50%;transform:translateY(-50%);width:140px;height:140px;opacity:.92;pointer-events:none}@media(max-width:680px){.jf-case-hero-art{display:none}}.jf-case-chips{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 26px}.jf-case-chips a{display:inline-block;padding:7px 14px;border:1px solid #d9e9e9;border-radius:999px;color:#004d4d;background:#f5fafa;font-size:13.5px;font-weight:600;text-decoration:none;transition:.15s}.jf-case-chips a:hover{background:#e6f3f3;border-color:#4db8b8}.jf-case-chips a.hl{background:#008080;color:#fff;border-color:#008080}.jf-case-list{display:flex;flex-direction:column;gap:12px}.jf-case{border:1px solid #d9e9e9;border-radius:12px;overflow:hidden;background:#fff}.jf-acc{position:absolute;width:1px;height:1px;opacity:0;overflow:hidden}.jf-acc-sum{display:flex;gap:12px;align-items:baseline;padding:15px 20px;cursor:pointer;font-weight:700;color:#004d4d;font-size:16px}.jf-acc-sum .cn{color:#008080;font-weight:800;min-width:58px}.jf-acc-sum .ct{color:#004d4d}.jf-acc-sum .meta{color:#7a8c8c;font-weight:600;font-size:13px}.jf-acc-sum:hover{background:#f5fafa}.jf-acc-body{display:none;border-top:1px solid #e3eded;padding:4px 20px 20px}.jf-acc:checked~.jf-acc-body{display:block}.jf-case-body{padding:4px 20px 20px}.jf-case-body table{width:100%;border-collapse:collapse;margin-top:6px}.jf-case-body td{border:1px solid #e3eded;padding:9px 12px;vertical-align:top;font-size:14.5px;color:#2f3d3d}.jf-case-body td.k{background:#f5fafa;color:#004d4d;font-weight:700;width:180px;white-space:nowrap}.jf-case-body td.out{color:#0a6b6b;font-weight:600}.jf-case-disc{background:#fff8e8;border:1px solid #c98a1a;border-radius:12px;padding:16px 22px;margin:28px 0 0;font-size:13px;color:#6b4f1a;line-height:1.6}.jf-case-back{margin-top:26px}.jf-case-back a{color:#008080!important;font-weight:600;text-decoration:none}<\/style>\n<section class=\"jf-case-hero\">\n<h1>Fulvik Asit Vaka Raporlar\u0131 &#8211; Metabolik ve Endokrin<\/h1>\n<p>Profesyonel B2B referans\u0131 i\u00e7in derlenmi\u015f, g\u0131dada kullan\u0131labilir fulvik asidin oral ve topikal kullan\u0131m\u0131na ili\u015fkin hasta taraf\u0131ndan bildirilen 23 vaka g\u00f6zlemi. Sonu\u00e7lar ki\u015finin kendisi taraf\u0131ndan raporlan\u0131r ve ki\u015fiye g\u00f6re de\u011fi\u015fir.<\/p>\n<div class=\"jf-case-hero-art\"><svg viewBox=\"0 0 120 120\" fill=\"none\" stroke=\"#eaffff\" stroke-width=\"3.4\" stroke-linecap=\"round\" stroke-linejoin=\"round\" aria-hidden=\"true\"><path d=\"M60 18c15 19 23 29 23 42a23 23 0 0 1-46 0c0-13 8-23 23-42Z\"\/><circle cx=\"60\" cy=\"60\" r=\"6\" fill=\"#eaffff\" stroke=\"none\"\/><circle cx=\"60\" cy=\"30\" r=\"3\" fill=\"#eaffff\" stroke=\"none\"\/><circle cx=\"90\" cy=\"58\" r=\"3\" fill=\"#eaffff\" stroke=\"none\"\/><circle cx=\"30\" cy=\"58\" r=\"3\" fill=\"#eaffff\" stroke=\"none\"\/><circle cx=\"60\" cy=\"86\" r=\"3\" fill=\"#eaffff\" stroke=\"none\"\/><\/svg><\/div>\n<\/section>\n<div class=\"jf-case-chips\"><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/digestive-system\/\">Sindirim Sa\u011fl\u0131\u011f\u0131<\/a><a class=\"hl\" href=\"https:\/\/www.jingfenggroup.com\/metabolic-endocrine\/\">Metabolik ve Endokrin<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/gynecological\/\">Jinekolojik<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/skin\/\">Cilt ve Dermatoloji<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/respiratory\/\">Solunum<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/musculoskeletal\/\">Kas-iskelet sistemi<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/cardio-cerebro\/\">Kardiyo ve Serebrovask\u00fcler<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/immune-hematologic\/\">Ba\u011f\u0131\u015f\u0131kl\u0131k ve Hematolojik<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/ophthalmologic\/\">Oftalmolojik (G\u00f6z)<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/oncological\/\">Onkolojik Destek<\/a><a class=\"\" href=\"https:\/\/www.jingfenggroup.com\/other-conditions\/\">Di\u011fer Ko\u015fullar<\/a><\/div>\n<div class=\"jf-case-list\">\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-9\" class=\"jf-acc\"><label for=\"case-9\" class=\"jf-acc-sum\"><span class=\"cn\">Durum 9<\/span><span class=\"ct\">Tiroid T\u00fcm\u00f6r\u00fc<\/span><span class=\"meta\">\u00b7 50F \u00b7 Suzhou, Anhui<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u8d75\u7d20\u4fa0 (Zhao Suxia)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>50<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Chenzhuang K\u00f6y\u00fc, Lizhuang Kasabas\u0131, Dangshan \u0130l\u00e7esi, Suzhou, Anhui, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1895577****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hasta, boynunun sol taraf\u0131nda bir \u00e7\u0131k\u0131nt\u0131 nedeniyle May\u0131s 2018&#8217;de Xuzhou T\u0131p \u00dcniversitesi&#8217;ne Ba\u011fl\u0131 Hastanede muayene edildi: tiroid t\u00fcm\u00f6r\u00fc &#8211; sol tiroid lobunun (en b\u00fcy\u00fck \u00e7ap 0,5 cm) kalsifikasyonlu, kaps\u00fcl \u00e7evresindeki tiroid dokusunu i\u00e7eren papiller mikrokarsinomu; sa\u011f lob ve istmusta, \u00e7evredeki iskelet kas\u0131n\u0131n invazyonu ve lokal olarak aktif folik\u00fcler epitelyal h\u00fccre \u00e7o\u011falmas\u0131yla birlikte lenfositik tiroidit g\u00f6r\u00fcld\u00fc.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">May\u0131s 2018&#8217;den itibaren g\u00fcnde iki kez (sabah ve ak\u015fam) a\u00e7 karn\u0131na 30 ml fulvik asit ald\u0131 ve bu tedavi s\u0131ras\u0131nda herhangi bir \u00f6zel reaksiyon fark etmedi. Daha sonra morali iyiydi, v\u00fccudu a\u011fr\u0131dan kurtuldu ve sa\u011fl\u0131k indeksleri benzer hastalara g\u00f6re olduk\u00e7a y\u00fcksekti.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-10\" class=\"jf-acc\"><label for=\"case-10\" class=\"jf-acc-sum\"><span class=\"cn\">Durum 10<\/span><span class=\"ct\">Tip 2 Diyabet<\/span><span class=\"meta\">\u00b7 58F \u00b7 Suzhou, Anhui<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5b59\u51e4\u6797 (G\u00fcne\u015f Fenglin)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>58<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Chengguan Kasabas\u0131, Dangshan \u0130l\u00e7esi, Suzhou, Anhui, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Kendini iyi hissetmeyen hastaya 1997 y\u0131l\u0131nda Jiangsu&#8217;daki Xuzhou 2 Nolu Halk Hastanesinde diyabet te\u015fhisi konuldu. 6 Temmuz 2018&#8217;de kan \u015fekeri 13,6 olarak tekrar ayn\u0131 hastaneye ba\u015fvurdu; Hastanede bir hafta kald\u0131ktan sonra \u015fekeri 10,5 \u00e7\u0131kt\u0131.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Temmuz 2018&#8217;den itibaren 21 g\u00fcn boyunca a\u00e7 karn\u0131na g\u00fcnde iki kez (sabah ve ak\u015fam) 50 ml fulvik asit alm\u0131\u015ft\u0131r. Kan \u015fekeri 6,0&#8217;a d\u00fc\u015ft\u00fc; zihinsel durumu m\u00fckemmeldi, i\u015ftah\u0131 iyiydi ve glikoz seviyesi stabildi.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-13\" class=\"jf-acc\"><label for=\"case-13\" class=\"jf-acc-sum\"><span class=\"cn\">Durum 13<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 53M \u00b7 Daqing, Heilongjiang<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u9ec4\u6587\u7965 (Huang Wenxiang)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>53<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Ranghulu B\u00f6lgesi, Daqing, Heilongjiang, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hasta 24 y\u0131ld\u0131r diyabet hastas\u0131yd\u0131, kan \u015fekeri yakla\u015f\u0131k 15&#8217;ti ve g\u00fcnde \u00fc\u00e7 ins\u00fclin enjeksiyonu yap\u0131l\u0131yordu.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">6 Nisan 2018&#8217;den itibaren fulvik asit ald\u0131. Yar\u0131m ay sonra Pekin 301 Hastanesi&#8217;nde yap\u0131lan muayenede kan \u015fekerinin 10,5&#8217;e d\u00fc\u015ft\u00fc\u011f\u00fc g\u00f6r\u00fcld\u00fc; bir ay sonra 5.6-6.1 civar\u0131ndayd\u0131. O zamandan beri ins\u00fclini ve di\u011fer t\u00fcm ila\u00e7lar\u0131 ask\u0131ya ald\u0131. Gastrointestinal fonksiyonu \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015fti ve morali m\u00fckemmel.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-15\" class=\"jf-acc\"><label for=\"case-15\" class=\"jf-acc-sum\"><span class=\"cn\">Durum 15<\/span><span class=\"ct\">Diyabet, Koroner Kalp Hastal\u0131\u011f\u0131 ve Hipertansiyon<\/span><span class=\"meta\">\u00b7 60F \u00b7 Suzhou, Anhui<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u4efb\u7d20\u5a1f (Ren Sujuan)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>60<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Dangshan \u0130l\u00e7esi, Suzhou, Anhui, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hastan\u0131n aile ge\u00e7mi\u015finde diyabet, koroner kalp hastal\u0131\u011f\u0131 ve hipertansiyon vard\u0131 ve uzun s\u00fcreli hastal\u0131\u011fa katlan\u0131yordu.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">2015 y\u0131l\u0131nda, biraz d\u00fczensiz bir \u015fekilde doz ba\u015f\u0131na 30-50 ml fulvik asit almaya ba\u015flad\u0131. Daha \u00f6nce y\u0131lda 2-3 kez hastaneye kald\u0131r\u0131l\u0131yordu; o zamandan bu yana ge\u00e7en \u00fc\u00e7 y\u0131l i\u00e7inde yaln\u0131zca bir kez hastaneye kald\u0131r\u0131ld\u0131. Xuzhou 2 Nolu Halk Hastanesinde yap\u0131lan muayene \u015funu g\u00f6sterdi: kan \u015fekeri 7,2 civar\u0131nda, kan bas\u0131nc\u0131 normal, koroner kalp durumu normal. \u015eu anda genel durumu m\u00fckemmel ve morali y\u00fcksek.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-21\" class=\"jf-acc\"><label for=\"case-21\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 21<\/span><span class=\"ct\">Hiper\u00fcrisemi<\/span><span class=\"meta\">\u00b7 42M \u00b7 Nanning, Guangxi<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u674e*\u817e (Li *Teng)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>42<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Zhongtian Y\u00fczy\u0131l Bah\u00e7esi, Nanning, Guangxi, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>13978***219<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Y\u0131llar s\u00fcren i\u015f e\u011flencesi nedeniyle, Eyl\u00fcl 2018&#8217;de Guangxi T\u0131p \u00dcniversitesi Birinci Ba\u011fl\u0131 Hastanesinde hastan\u0131n \u00fcrik asidi 649 olarak test edildi. \u00c7e\u015fitli \u00c7in ve Bat\u0131 ila\u00e7lar\u0131 hi\u00e7bir iyile\u015fme sa\u011flamad\u0131.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">9 Eyl\u00fcl 2018&#8217;den itibaren g\u00fcnde iki kez (sabah ve ak\u015fam) 50 ml fulvik asit ald\u0131. Bir ay sonra yap\u0131lan testte \u00fcrik asitin 429 oldu\u011fu g\u00f6r\u00fcld\u00fc. Fulvik asit almaya devam ediyor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-24\" class=\"jf-acc\"><label for=\"case-24\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 24<\/span><span class=\"ct\">Gut<\/span><span class=\"meta\">\u00b7 \u2014M \u00b7 Dezhou, \u015eandong<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u970d*\u6f6e (Huo *Chao)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Yolun 300 m do\u011fusunda, yeni otob\u00fcs terminalinin g\u00fcneyinde, Xiajin \u0130l\u00e7esi, Dezhou, Shandong, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1329028****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hasta y\u0131llard\u0131r gut hastas\u0131yd\u0131; \u00e7e\u015fitli \u00c7in ve Bat\u0131 ila\u00e7lar\u0131 hi\u00e7bir geli\u015fme sa\u011flamad\u0131.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Temmuz 2018&#8217;den itibaren \u00c7in t\u0131bb\u0131 haplar\u0131yla birlikte g\u00fcnde 10 ml fulvik asit kullanmaya ba\u015flad\u0131; bir TCM uygulay\u0131c\u0131s\u0131 daha sonra tamamen iyile\u015fti\u011fini do\u011frulad\u0131. (Not: Yukar\u0131daki isim ve telefon, kendi gut hastalar\u0131na fulvik asit veren TCM doktoru Dr. Huo&#8217;ya aittir.)<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-25\" class=\"jf-acc\"><label for=\"case-25\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 25<\/span><span class=\"ct\">Hipertansiyon ve D\u00fczensiz Menstruasyon<\/span><span class=\"meta\">\u00b7 39F \u00b7 Jiaozuo, Henan<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5218*\u7ea2 (Liu *Hong)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>39<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Beiguan K\u00f6y\u00fc, Chengguan Kasabas\u0131, Xiuwu, Jiaozuo, Henan, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1773779**36<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hasta k\u00f6t\u00fc uyuyordu ve hipertansiyon ve d\u00fczensiz adet kanamas\u0131ndan yak\u0131n\u0131yordu.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">A\u011fustos 2018&#8217;den itibaren g\u00fcnde iki kez (sabah ve ak\u015fam) 20 ml fulvik asit ald\u0131. \u0130lk ay boyunca her ak\u015fam saat ona kadar uyumaya ihtiya\u00e7 duydu\u011funu fark etti. Yar\u0131m ay i\u00e7inde Bat\u0131 t\u0131bb\u0131n\u0131 almay\u0131 tamamen b\u0131rakt\u0131. Regl d\u00f6nemi, yo\u011fun ve d\u00fczenli bir ak\u0131\u015fla yakla\u015f\u0131k yedi g\u00fcn s\u00fcrd\u00fc; uyku belirgin \u015fekilde iyile\u015fti; ve s\u0131k s\u0131k ge\u011firme sorunu da \u00e7\u00f6z\u00fclm\u00fc\u015ft\u00fc.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-29\" class=\"jf-acc\"><label for=\"case-29\" class=\"jf-acc-sum\"><span class=\"cn\">Durum 29<\/span><span class=\"ct\">Hipertansiyon, \u0130nme ve Hiperglisemi<\/span><span class=\"meta\">\u00b7 60M \u00b7 Suzhou, Anhui<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5de9\u7389\u79cb (Gong Yuqiu)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>60<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>363 Renmin West Rd., Dangshan \u0130l\u00e7esi, Suzhou, Anhui, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1825570****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hastan\u0131n y\u0131l boyunca hipertansiyonu vard\u0131 (diyastolik 100 civar\u0131nda, sistolik 160 ile 170 aras\u0131nda) ve y\u0131llarca antihipertansif ila\u00e7lara yan\u0131t yoktu. Ayr\u0131ca y\u00fcz\u00fcnde hafif bir sarkma ve s\u0131k ins\u00fclin enjeksiyonu gerektiren kan \u015fekerinin 12&#8217;nin \u00fczerinde oldu\u011fu hiperglisemi ile fel\u00e7 ge\u00e7irmi\u015fti.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">2017 y\u0131l\u0131nda fel\u00e7 ge\u00e7irdikten sonra a\u00e7 karn\u0131na g\u00fcnde iki kez (sabah ve ak\u015fam) 50 ml fulvik asit almaya ba\u015flad\u0131. \u0130lk aydan sonra sistolik bas\u0131nc\u0131 140&#8217;a d\u00fc\u015ft\u00fc; bir ay sonra 120&#8217;ye. \u200b\u200bBe\u015f ay sonra diyastolik de\u011feri 70-80&#8217;de ve sistolik de\u011feri 120-130&#8217;da &#8211; normal de\u011ferler &#8211; stabille\u015fti ve o zamandan beri antihipertansif kullanmad\u0131. Ayn\u0131 ay i\u00e7erisinde fulvik asit art\u0131 ek tedavi ile fel\u00e7 sekeli d\u00fczeldi ve d\u00fc\u015f\u00fc\u015f ortadan kalkt\u0131. Bug\u00fcn h\u00e2l\u00e2 ins\u00fclin enjekte ediyor ama daha az s\u0131kl\u0131kta; \u015eekeri 12&#8217;nin \u00fcst\u00fcnden 10&#8217;un alt\u0131na d\u00fc\u015ft\u00fc.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-43\" class=\"jf-acc\"><label for=\"case-43\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 43<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 73M \u00b7 Dangshan \u0130l\u00e7esi, Anhui<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>Xu Chaogang (Xu Chaogang)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>73<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Dangshan \u0130l\u00e7esi, Anhui, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hastan\u0131n diyabeti vard\u0131; uzun s\u00fcreli ila\u00e7 tedavisi etkisizdi.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">25 Ekim 2018&#8217;de fulvik asit almaya ba\u015flad\u0131. On g\u00fcn sonra kan \u015fekeri 11,3&#8217;ten 9,3&#8217;e d\u00fc\u015ft\u00fc. Uykusu d\u00fczeldi ve morali iyi; hala al\u0131yor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-57\" class=\"jf-acc\"><label for=\"case-57\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 57<\/span><span class=\"ct\">Gut<\/span><span class=\"meta\">\u00b7 44M \u00b7 Handan, Hebei<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u6768\u90b1\u5cf0 (Yang Qiufeng)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>44<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Xinzeyuan Malikanesi, Congtai B\u00f6lgesi, Handan, Hebei, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1863003****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hasta alt\u0131 y\u0131ld\u0131r \u00fcrik asit seviyesi 645 civar\u0131nda olan gut hastas\u0131yd\u0131. Bir\u00e7ok ithal ila\u00e7 \u00e7ok az etki yaratt\u0131. 2017 ile May\u0131s 2018 aras\u0131nda olas\u0131 her tetikleyici g\u0131dadan ka\u00e7\u0131nd\u0131, ancak yine de yakla\u015f\u0131k her 15 g\u00fcnde bir, b\u00fcy\u00fck bir s\u0131k\u0131nt\u0131 kayna\u011f\u0131 olan alevlenme ya\u015fad\u0131.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">May\u0131s 2018&#8217;den itibaren sabah ve ak\u015fam a\u00e7 karn\u0131na 50 ml, ayr\u0131ca geceleri ayak banyosunda (a\u00e7\u0131k ve kapal\u0131) 50 ml fulvik asit ald\u0131. Be\u015f g\u00fcn sonra durumu hafifledi. May\u0131s 2018&#8217;de yap\u0131lan bir test, \u00fcrik asidin 620&#8217;ye hafif\u00e7e d\u00fc\u015ft\u00fc\u011f\u00fcn\u00fc g\u00f6sterdi; 15 Kas\u0131m 2018&#8217;e (g\u00fcn\u00fcm\u00fcze) kadar ba\u015fka i\u015faret fi\u015fe\u011fi ya\u015famad\u0131. Art\u0131k her ak\u015fam fulvik asit banyosuna giriyor ve g\u00f6zlemlemeye devam ediyor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-59\" class=\"jf-acc\"><label for=\"case-59\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 59<\/span><span class=\"ct\">Tiroid Nod\u00fcl\u00fc<\/span><span class=\"meta\">\u00b7 61F \u00b7 Harbin, Heilongjiang<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u97e9\u7ea2\u971e (Han Hongxia)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>61<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Xingfu Kasabas\u0131, Xiangfang B\u00f6lgesi, Harbin, Heilongjiang, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1868686****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>4 Ocak 2017&#8217;de Hainan 301 Hastanesindeki BT incelemesinde sol tiroid lobunda 0,7 x 0,4 x 0,6 cm boyutlar\u0131nda kar\u0131\u015f\u0131k kistik-solid nod\u00fcl g\u00f6r\u00fcld\u00fc. \u00dc\u00e7 ayl\u0131k Bat\u0131 t\u0131bb\u0131n\u0131n ard\u0131ndan, 7 Nisan 2017&#8217;de ayn\u0131 hastanede, ayn\u0131 taray\u0131c\u0131da ve ayn\u0131 doktorda tekrarlanan CT&#8217;de hi\u00e7bir de\u011fi\u015fiklik g\u00f6r\u00fclmedi.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">26 Eyl\u00fcl 2017&#8217;den itibaren g\u00fcnde \u00fc\u00e7 kez (sabah, \u00f6\u011flen, ak\u015fam), her seferinde a\u00e7 karn\u0131na 30 ml olmak \u00fczere fulvik asit alm\u0131\u015ft\u0131r. 83 g\u00fcn sonra, 18 Aral\u0131k 2017&#8217;de Hainan 301 Hastanesi&#8217;nde (ayn\u0131 taray\u0131c\u0131, ayn\u0131 doktor) yap\u0131lan CT, sol lobdaki kar\u0131\u015f\u0131k kistik-solid nod\u00fcl\u00fcn art\u0131k 2,0 x 0,6 mm boyutlar\u0131nda oldu\u011funu g\u00f6sterdi: santimetreden milimetreye kadar tam 5 x 3,4 mm daha k\u00fc\u00e7\u00fck; doktor hayrete d\u00fc\u015ft\u00fc. 14 A\u011fustos 2018&#8217;de Harbin T\u0131p \u00dcniversitesi Hastanesi&#8217;nde yap\u0131lan ba\u015fka bir BT&#8217;de tiroid anormalli\u011fi g\u00f6r\u00fclmedi. Dokuz ayl\u0131k fulvik asit tedavisinin ard\u0131ndan nod\u00fcl tamamen ortadan kaybolmu\u015ftu.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-65\" class=\"jf-acc\"><label for=\"case-65\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 65<\/span><span class=\"ct\">Hiperglisemi<\/span><span class=\"meta\">\u00b7 60M \u00b7 Weifang, \u015eandong<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5468 * (Zhou *)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>60<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Weifang, Shandong, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hastada y\u00fcksek kan \u015fekeri ve kan lipitleri, kal\u0131n kan ve tromboz mevcuttu. Y\u0131l boyunca kan suland\u0131r\u0131c\u0131 i\u011fneler ve her g\u00fcn antihipertansif haplar al\u0131yordu; A\u00e7l\u0131k \u015fekeri 6,5 civar\u0131ndayd\u0131.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">14 Ocak 2018&#8217;de fulvik asit almaya ba\u015flad\u0131. Yedi g\u00fcn sonra a\u00e7l\u0131k \u015fekeri 5,7&#8217;ye d\u00fc\u015ft\u00fc. Hala al\u0131yor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-71\" class=\"jf-acc\"><label for=\"case-71\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 71<\/span><span class=\"ct\">Tiroid Nod\u00fcl\u00fc<\/span><span class=\"meta\">\u00b7 43F \u00b7 Guangzhou, Guangdong<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u80e1* (Hu*)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>43<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Fuqian Rd., Jiekou Caddesi, Conghua B\u00f6lgesi, Guangzhou, Guangdong, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>May\u0131s 2018&#8217;de hastada yakla\u015f\u0131k 14 x 11 x 8 mm boyutlar\u0131nda bir tiroid nod\u00fcl\u00fc oldu\u011fu tespit edildi; hi\u00e7bir ila\u00e7 almad\u0131.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Kas\u0131m 2018&#8217;den itibaren a\u00e7 karn\u0131na g\u00fcnde iki kez (sabah ve ak\u015fam) 30 ml fulvik asit almaya ba\u015flad\u0131. \u0130ki ayl\u0131k s\u00fcrekli kullan\u0131m\u0131n ard\u0131ndan, hastane muayenesinde nod\u00fcl\u00fcn yakla\u015f\u0131k 11 x 8 x 7 mm&#8217;ye k\u00fc\u00e7\u00fcld\u00fc\u011f\u00fc ve uykusunun ve moralinin belirgin \u015fekilde d\u00fczeldi\u011fi g\u00f6r\u00fcld\u00fc.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-72\" class=\"jf-acc\"><label for=\"case-72\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 72<\/span><span class=\"ct\">Tiroid Nod\u00fcl\u00fc<\/span><span class=\"meta\">\u00b7 40F \u00b7 Conghua, Guangdong<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u6797** (Lin **)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>40<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Gangwan Rd., Jiekou Caddesi, Conghua, Guangdong, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>13642****80<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>2018&#8217;in ba\u015flar\u0131nda hastada yakla\u015f\u0131k 17 x 13 mm boyutlar\u0131nda bir tiroid nod\u00fcl\u00fc oldu\u011fu tespit edildi; biyopside atipik lezyonlar g\u00f6r\u00fcld\u00fc.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Kas\u0131m 2018&#8217;den itibaren a\u00e7 karn\u0131na g\u00fcnde iki kez (sabah ve ak\u015fam) 30 ml fulvik asit almaya ba\u015flad\u0131. \u0130ki ayl\u0131k s\u00fcrekli kullan\u0131m\u0131n ard\u0131ndan yap\u0131lan incelemede, nod\u00fcl\u00fcn karakterinde bir de\u011fi\u015fiklikle birlikte yakla\u015f\u0131k 15 x 12 mm&#8217;ye hafif\u00e7e k\u00fc\u00e7\u00fcld\u00fc\u011f\u00fc g\u00f6r\u00fcld\u00fc; doktor inflamasyonu en olas\u0131 tan\u0131 olarak de\u011ferlendirdi.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-74\" class=\"jf-acc\"><label for=\"case-74\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 74<\/span><span class=\"ct\">Gut<\/span><span class=\"meta\">\u00b7 67 milyon \u00b7 Guangzhou, Guangdong<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5f20*\u8f89 (Zhang *Hui)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>67<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Tianhe Kuzey Rd., Tianhe B\u00f6lgesi, Guangzhou, Guangdong, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1581883***8<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Hastan\u0131n on y\u0131ldan fazla s\u00fcredir gut \u00f6yk\u00fcs\u00fc vard\u0131, alkolden ho\u015flan\u0131yordu ve s\u0131k s\u0131k \u00e7ok s\u0131k\u0131nt\u0131l\u0131 ataklar ge\u00e7iriyordu.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Aral\u0131k 2018&#8217;den itibaren a\u00e7 karn\u0131na g\u00fcnde iki kez (sabah ve ak\u015fam) 30 ml fulvik asit ald\u0131. 10 g\u00fcn sonra a\u011fr\u0131 belirgin bir \u015fekilde azald\u0131. 45 g\u00fcnden fazla s\u00fcrekli kullan\u0131mla, alkol i\u00e7tikten sonra durum stabil bir \u015fekilde kontrol alt\u0131na al\u0131nd\u0131; hatta bu alevlenmeler bile eskisinden daha hafif.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-77\" class=\"jf-acc\"><label for=\"case-77\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 77<\/span><span class=\"ct\">Solunum Yolu Enfeksiyonu, Bron\u015fit, Y\u00fcksek Riskli Hipertansiyon, Arterioskleroz ve Serebral Enfarkt\u00fcs<\/span><span class=\"meta\">\u00b7 B. Eyl\u00fcl 1939M \u00b7 Xi&#8217;an, \u015eaanksi<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5b8b\u632f\u4e1c (\u015eark\u0131 Zhendong)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>B. Eyl\u00fcl 1939<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Rm. 201, \u00dcnite 2, Gujiling Malikanesi, Dongguan G\u00fcney St., Xi&#8217;an, Shaanxi, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1830683****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>21 Kas\u0131m 2018&#8217;de Kuangren Hastanesinde (Xi&#8217;an Jiaotong \u00dcniversitesi T\u0131p Fak\u00fcltesine Ba\u011fl\u0131 Hastane) yap\u0131lan muayenede \u015funlar g\u00f6r\u00fcld\u00fc: solunum yolu enfeksiyonu, bron\u015fit, y\u00fcksek riskli hipertansiyon, arterioskleroz ve beyin enfarkt\u00fcs\u00fc. Uzun s\u00fcreli ila\u00e7 tedavisi v\u00fccudunu giderek daha zay\u0131f hale getirmi\u015fti ve asl\u0131nda tedaviyi b\u0131rakm\u0131\u015ft\u0131.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">1. Deneme s\u00fcresi: 14 Ocak 2019&#8217;dan itibaren, klini\u011fin \u00c7in t\u0131bb\u0131na ek olarak, 30 g\u00fcn boyunca, g\u00fcnde iki kez, doz ba\u015f\u0131na 50 ml Fulvikang Bile\u015fik Mineral Bitkisel \u0130\u00e7ecek (g\u0131da s\u0131n\u0131f\u0131) ekledi. 2. Sonu\u00e7lar: Etki \u00e7ok a\u00e7\u0131kt\u0131; art\u0131k rahat uyuyor, i\u015ftah\u0131 b\u00fcy\u00fck \u00f6l\u00e7\u00fcde artt\u0131, kalp at\u0131\u015f h\u0131z\u0131 ve kan bas\u0131nc\u0131 esasen normale d\u00f6nd\u00fc ve zihinsel durumu iyile\u015fmeye devam ediyor. G\u00f6zlem alt\u0131na almaya devam ediyor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-86\" class=\"jf-acc\"><label for=\"case-86\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 86<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 46 milyon \u00b7 \u2014<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5434\u660c\u987a (Wu Changshun)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>46<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1810557****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>15 y\u0131ld\u0131r diyabet; tedaviden \u00f6nce kan \u015fekeri 12.7, bulan\u0131k g\u00f6rme ve ba\u015f d\u00f6nmesi ile birlikte.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Bir hafta sonra glikoz 14&#8217;e y\u00fckseldi, ard\u0131ndan yakla\u015f\u0131k yar\u0131m ay s\u00fcren kullan\u0131m\u0131n ard\u0131ndan 8,5&#8217;e d\u00fc\u015ft\u00fc. G\u00f6r\u00fc\u015f\u00fc art\u0131k normal ve ba\u015f d\u00f6nmesi gitti; hala al\u0131yor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-87\" class=\"jf-acc\"><label for=\"case-87\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 87<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 \u2014F \u00b7 Linqing, \u015eandong<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5218\u57f9\u82f1 (Liu Peiying)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>\u2014<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Trafik Polisi M\u00fcfrezesi, Linqing, Shandong, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1396956****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Yirmi y\u0131l\u0131 a\u015fk\u0131n s\u00fcredir diyabet: sabah ve ak\u015fam glikoz d\u00fc\u015f\u00fcr\u00fcc\u00fc tabletler art\u0131 g\u00fcnde 60 \u00fcnite ins\u00fclin.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Yirmi g\u00fcnl\u00fck fulvik asitten sonra art\u0131k oral glikoz d\u00fc\u015f\u00fcr\u00fcc\u00fc tabletlere ihtiyac\u0131 kalm\u0131yor, ins\u00fclini yar\u0131 yar\u0131ya d\u00fc\u015f\u00fcyor ve kan \u015fekeri d\u00fc\u015fmeye devam ediyor. F\u00fclvik asit almaya devam ediyor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-89\" class=\"jf-acc\"><label for=\"case-89\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 89<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 40M \u00b7 Daqing, Heilongjiang<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u738b\u592a\u6ce2 (Wang Taibo)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>40<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Ranghulu B\u00f6lgesi, Daqing, Heilongjiang, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1775884****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>7 Ekim 2018&#8217;deki hemoroit ameliyat\u0131nda hastane kan \u015fekerinin 24 ve idrar \u015fekerinin +++ oldu\u011funu tespit etti.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">2018 y\u0131l\u0131n\u0131n Kas\u0131m ay\u0131n\u0131n ba\u015flar\u0131nda g\u00fcnde iki kez (sabah ve ak\u015fam) 50 ml olmak \u00fczere fulvik asit tedavisine ba\u015flad\u0131. \u0130lk yar\u0131m ay d\u0131\u015fk\u0131lar gev\u015fekti, sonra her \u015fey normale d\u00f6nd\u00fc. Gece ge\u00e7 saatlere kadar \u00e7al\u0131\u015f\u0131yor, sabah 11 civar\u0131nda kalk\u0131yor ve diyet k\u0131s\u0131tlamas\u0131 olmaks\u0131z\u0131n g\u00fcnde iki \u00f6\u011f\u00fcn yemek yiyor. Oru\u00e7 glikozu: 20 Kas\u0131m&#8217;da 12,3; 2 Aral\u0131k&#8217;ta 11.4; 6 Ocak 2019&#8217;da 8.3; 16 \u015eubat&#8217;ta 10.4. Hala al\u0131yor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-94\" class=\"jf-acc\"><label for=\"case-94\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 94<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 64F \u00b7 Dangshan \u0130l\u00e7esi, Anhui<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u6c6a\u6842\u829d (Wang Guizhi)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>64<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Rm. 301, Birim 2, Bina. 9, Nancheng Malikanesi, Y\u00fcksek H\u0131zl\u0131 Tren Yeni B\u00f6lgesi, Dangshan \u0130l\u00e7esi, Anhui, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1585538****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Kan \u015fekerinin 14 oldu\u011fu uzun s\u00fcreli diyabet, d\u0131\u015fk\u0131 \u00e7\u0131karamama ve bulan\u0131k g\u00f6rme.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Aral\u0131k 2018&#8217;de fulvik asit almaya ba\u015flad\u0131. \u0130ki ay sonra glikozu 9&#8217;a d\u00fc\u015ft\u00fc, g\u00f6r\u00fc\u015f\u00fc netle\u015fti, i\u015ftah\u0131 artt\u0131 ve ba\u011f\u0131rsaklar\u0131 p\u00fcr\u00fczs\u00fczd\u00fc. Hala al\u0131yor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-98\" class=\"jf-acc\"><label for=\"case-98\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 98<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 62F \u00b7 Heihe, Heilongjiang<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u5f20\u4e3d\u840d (Zhang Liping)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Di\u015fi<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>62<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Heihe, Heilongjiang, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1384561****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Kan \u015fekeri s\u00fcrekli olarak 15.5&#8217;te olan diyabet.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Alt\u0131 ay s\u00fcren fulvik asitten sonra glikozu temelde 7&#8217;nin alt\u0131nda. Hala al\u0131yor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-99\" class=\"jf-acc\"><label for=\"case-99\" class=\"jf-acc-sum\"><span class=\"cn\">Durum 99<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 59M \u00b7 Daqing, Heilongjiang<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u9ec4\u6587\u7965 (Huang Wenxiang)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>59<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Ranghulu B\u00f6lgesi, Daqing, Heilongjiang, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1333959****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Genel halsizlikle birlikte kan \u015fekeri 12&#8217;de uzun.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Alt\u0131 ay s\u00fcren fulvik asitten sonra glikozu temel olarak 6,5 seviyesinde kontrol ediliyor.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<div class=\"jf-case\"><input type=\"checkbox\" id=\"case-100\" class=\"jf-acc\"><label for=\"case-100\" class=\"jf-acc-sum\"><span class=\"cn\">Vaka 100<\/span><span class=\"ct\">Diyabet<\/span><span class=\"meta\">\u00b7 55M \u00b7 Daqing, Heilongjiang<\/span><\/label><\/p>\n<div class=\"jf-acc-body\">\n<table>\n<tr>\n<td class=\"k\">\u0130sim<\/td>\n<td>\u53e4\u4fca\u5cad (Gu Junling)<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Cinsiyet<\/td>\n<td>Erkek<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Ya\u015f<\/td>\n<td>55<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">B\u00f6lge<\/td>\n<td>Ranghulu B\u00f6lgesi, Daqing, Heilongjiang, \u00c7in<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Temas etmek<\/td>\n<td>1313459****<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">T\u0131bbi Ge\u00e7mi\u015f ve Tan\u0131<\/td>\n<td>Kan \u015fekeri 9.6&#8217;da.<\/td>\n<\/tr>\n<tr>\n<td class=\"k\">Fulvik Asit Kullan\u0131m\u0131 Sonras\u0131 Bildirilen Sonu\u00e7<\/td>\n<td class=\"out\">Alt\u0131 ay boyunca fulvik asit kulland\u0131ktan sonra glikozu 6,8&#8217;e d\u00fc\u015ft\u00fc.<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"jf-case-disc\">Bu kay\u0131tlar, kontroll\u00fc klinik ara\u015ft\u0131rmalar\u0131n sonu\u00e7lar\u0131 de\u011fil, hastalar taraf\u0131ndan rapor edilen g\u00f6zlemlerdir. G\u0131da s\u0131n\u0131f\u0131 fulvik asit, farmas\u00f6tik bir ila\u00e7 de\u011fil, besin takviyesi ham maddesidir. \u0130fadelerin herhangi bir hastal\u0131\u011f\u0131 te\u015fhis etme, tedavi etme, tedavi etme veya \u00f6nleme amac\u0131 yoktur. Bireysel sonu\u00e7lar farkl\u0131l\u0131k g\u00f6sterir; daima kalifiye bir sa\u011fl\u0131k uzman\u0131na dan\u0131\u015f\u0131n. Yaln\u0131zca profesyonel B2B referans\u0131.<\/div>\n<div class=\"jf-case-back\"><a href=\"\/human-health-fulvic-acid\/\">\u2190 T\u00fcm vaka raporlar\u0131na geri d\u00f6n<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>23 patient-reported case observations from food-grade fulvic acid use (Metabolic &#038; Endocrine). Professional B2B reference.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"home_why_img":"","home_why_small_title":"","home_why_title":"","home_why_text":"","home_why_btn_text":"","home_why_btn_link":"","home_why_benefits":[],"footnotes":""},"class_list":["post-1340","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Fulvic Acid Durum Raporlar\u0131 Metabolik &amp; Endokrin<\/title>\n<meta name=\"description\" content=\"23 patient-reported Metabolic &amp; Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.jingfenggroup.com\/tr\/metabolic-endocrine\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:locale:alternate\" content=\"en_US\" \/>\n<meta property=\"og:locale:alternate\" content=\"ja\" \/>\n<meta property=\"og:locale:alternate\" content=\"ko_KR\" \/>\n<meta property=\"og:locale:alternate\" content=\"es_ES\" \/>\n<meta property=\"og:locale:alternate\" content=\"ar\" \/>\n<meta property=\"og:locale:alternate\" content=\"vi\" \/>\n<meta property=\"og:locale:alternate\" content=\"th\" \/>\n<meta property=\"og:locale:alternate\" content=\"ru_RU\" \/>\n<meta property=\"og:locale:alternate\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fulvic Acid Durum Raporlar\u0131 Metabolik &amp; Endokrin\" \/>\n<meta property=\"og:description\" content=\"23 patient-reported Metabolic &amp; Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.jingfenggroup.com\/tr\/metabolic-endocrine\/\" \/>\n<meta property=\"og:site_name\" content=\"JINGFENG GROUP\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-20T17:28:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.jingfenggroup.com\/wp-content\/uploads\/2026\/09\/jf-factory-01.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1067\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Fulvic Acid Durum Raporlar\u0131 Metabolik &amp; Endokrin\" \/>\n<meta name=\"twitter:description\" content=\"23 patient-reported Metabolic &amp; Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"86 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.jingfenggroup.com\\\/metabolic-endocrine\\\/\",\"url\":\"https:\\\/\\\/www.jingfenggroup.com\\\/metabolic-endocrine\\\/\",\"name\":\"Fulvic Acid Durum Raporlar\u0131 Metabolik & Endokrin\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jingfenggroup.com\\\/#website\"},\"datePublished\":\"2026-09-16T06:00:46+00:00\",\"dateModified\":\"2026-10-20T17:28:37+00:00\",\"description\":\"23 patient-reported Metabolic & Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.jingfenggroup.com\\\/metabolic-endocrine\\\/#breadcrumb\"},\"inLanguage\":\"tr-TR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.jingfenggroup.com\\\/metabolic-endocrine\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.jingfenggroup.com\\\/metabolic-endocrine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.jingfenggroup.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fulvic Acid Case Reports \u2014 Metabolic &#038; Endocrine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.jingfenggroup.com\\\/#website\",\"url\":\"https:\\\/\\\/www.jingfenggroup.com\\\/\",\"name\":\"JINGFENG GROUP\",\"description\":\"JINGFENG GROUP\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.jingfenggroup.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr-TR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Fulvic Acid Durum Raporlar\u0131 Metabolik & Endokrin","description":"23 patient-reported Metabolic & Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.jingfenggroup.com\/tr\/metabolic-endocrine\/","og_locale":"tr_TR","og_type":"article","og_title":"[:en]Fulvic Acid Case Reports \u2014 Metabolic & Endocrine[:ja]\u30d5\u30eb\u30d3\u30c3\u30af\u9178\u75c7\u4f8b\u5831\u544a \u30e1\u30bf\u30dc\u30ea\u30c3\u30af&\u30a8\u30f3\u30c9\u30af\u30ed\u30ea\u30f3[:ko]\ud480\ube44\ud06c\uc0b0 \uc0ac\uac74 \ubcf4\uace0\uc11c\ub294 Metabolic & Endocrine[:es]Fulvic Acid Case Reports Metabolic & Endocrine[:ar]\u062a\u0642\u0627\u0631\u064a\u0631 \u0642\u0636\u064a\u0629 \u062d\u0645\u0636 \u0627\u0644\u0641\u0648\u0644\u0641\u064a\u0643 \u0627\u0644\u0623\u064a\u0636 \u0648\u0627\u0644\u0625\u0646\u062f\u0648\u0643\u0631\u064a\u0646[:vi]Fulvic Acid Case Reports Metabolic & Endocrine[:th]Fulvic Acid Case Reports \u0e42\u0e23\u0e04\u0e2a\u0e01\u0e31\u0e14\u0e41\u0e25\u0e30\u0e2d\u0e2d\u0e19\u0e42\u0e14\u0e04\u0e23\u0e35\u0e19[:tr]Fulvic Acid Durum Raporlar\u0131 Metabolik & Endokrin[:ru]Fulvic Acid Case Reports \u041c\u0435\u0442\u0430\u0431\u043e\u043b\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0438 \u044d\u043d\u0434\u043e\u043a\u0440\u0438\u043d\u043e\u0432\u044b\u0435 \u043f\u0440\u043e\u0446\u0435\u0441\u0441\u044b.[:pt]Relat\u00f3rios de casos com \u00e1cido fulvico Metabolic & Endocrine","og_description":"23 patient-reported Metabolic & Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.","og_url":"https:\/\/www.jingfenggroup.com\/tr\/metabolic-endocrine\/","og_site_name":"JINGFENG GROUP","article_modified_time":"2026-10-20T17:28:37+00:00","og_image":[{"width":1067,"height":800,"url":"https:\/\/www.jingfenggroup.com\/wp-content\/uploads\/2026\/09\/jf-factory-01.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_title":"[:en]Fulvic Acid Case Reports \u2014 Metabolic & Endocrine[:ja]\u30d5\u30eb\u30d3\u30c3\u30af\u9178\u75c7\u4f8b\u5831\u544a \u30e1\u30bf\u30dc\u30ea\u30c3\u30af&\u30a8\u30f3\u30c9\u30af\u30ed\u30ea\u30f3[:ko]\ud480\ube44\ud06c\uc0b0 \uc0ac\uac74 \ubcf4\uace0\uc11c\ub294 Metabolic & Endocrine[:es]Fulvic Acid Case Reports Metabolic & Endocrine[:ar]\u062a\u0642\u0627\u0631\u064a\u0631 \u0642\u0636\u064a\u0629 \u062d\u0645\u0636 \u0627\u0644\u0641\u0648\u0644\u0641\u064a\u0643 \u0627\u0644\u0623\u064a\u0636 \u0648\u0627\u0644\u0625\u0646\u062f\u0648\u0643\u0631\u064a\u0646[:vi]Fulvic Acid Case Reports Metabolic & Endocrine[:th]Fulvic Acid Case Reports \u0e42\u0e23\u0e04\u0e2a\u0e01\u0e31\u0e14\u0e41\u0e25\u0e30\u0e2d\u0e2d\u0e19\u0e42\u0e14\u0e04\u0e23\u0e35\u0e19[:tr]Fulvic Acid Durum Raporlar\u0131 Metabolik & Endokrin[:ru]Fulvic Acid Case Reports \u041c\u0435\u0442\u0430\u0431\u043e\u043b\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0438 \u044d\u043d\u0434\u043e\u043a\u0440\u0438\u043d\u043e\u0432\u044b\u0435 \u043f\u0440\u043e\u0446\u0435\u0441\u0441\u044b.[:pt]Relat\u00f3rios de casos com \u00e1cido fulvico Metabolic & Endocrine","twitter_description":"23 patient-reported Metabolic & Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.","twitter_misc":{"Est. reading time":"86 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.jingfenggroup.com\/metabolic-endocrine\/","url":"https:\/\/www.jingfenggroup.com\/metabolic-endocrine\/","name":"Fulvic Acid Durum Raporlar\u0131 Metabolik & Endokrin","isPartOf":{"@id":"https:\/\/www.jingfenggroup.com\/#website"},"datePublished":"2026-09-16T06:00:46+00:00","dateModified":"2026-10-20T17:28:37+00:00","description":"23 patient-reported Metabolic & Endocrine case reports from food-grade fulvic acid use. Professional B2B reference.","breadcrumb":{"@id":"https:\/\/www.jingfenggroup.com\/metabolic-endocrine\/#breadcrumb"},"inLanguage":"tr-TR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.jingfenggroup.com\/metabolic-endocrine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.jingfenggroup.com\/metabolic-endocrine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.jingfenggroup.com\/"},{"@type":"ListItem","position":2,"name":"Fulvic Acid Case Reports \u2014 Metabolic &#038; Endocrine"}]},{"@type":"WebSite","@id":"https:\/\/www.jingfenggroup.com\/#website","url":"https:\/\/www.jingfenggroup.com\/","name":"JINGFENG GROUP","description":"JINGFENG GROUP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.jingfenggroup.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr-TR"}]}},"_links":{"self":[{"href":"https:\/\/www.jingfenggroup.com\/tr\/wp-json\/wp\/v2\/pages\/1340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.jingfenggroup.com\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.jingfenggroup.com\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.jingfenggroup.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jingfenggroup.com\/tr\/wp-json\/wp\/v2\/comments?post=1340"}],"version-history":[{"count":0,"href":"https:\/\/www.jingfenggroup.com\/tr\/wp-json\/wp\/v2\/pages\/1340\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.jingfenggroup.com\/tr\/wp-json\/wp\/v2\/media?parent=1340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}